Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Birzeit Pharmaceutical CoXPAE:BPC -0.27%91 Dividend Yield % is 1.36% as of Jul. 15, 2026, which is 62% below its 10-year median of 3.59. GuruFocus rates XPAE:BPC with a GF Score™ of 91/100 and a GF Value™ of $4.59 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 515 Drug Manufacturers companies, Birzeit Pharmaceutical Co ranks worse than 61.55% on this metric.
During the past 3 years, the average Dividends Per Share Growth Rate was -29.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -20.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Birzeit Pharmaceutical Co was 17.00% per year. The lowest was -29.20% per year. And the median was -13.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Birzeit Pharmaceutical Co (XPAE:BPC) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAE:BPC vs ZTS, UTHR, VTRS: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Birzeit Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Birzeit Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Birzeit Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Birzeit Pharmaceutical Co's Dividend Yield % falls into.
Birzeit Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Birzeit Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.050000
2026-05-06
2026-05-07
2026-07-15
Cash Dividend
annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Birzeit Pharmaceutical Co (XPAE:BPC) has a Dividend Yield % of 1.36% as of Jul. 15, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Birzeit Pharmaceutical Co and its competitors. This is 62% below median its historical median of 3.59. Over the past decade, Birzeit Pharmaceutical Co's Dividend Yield % has ranged from 1.12 to 6.33. According to the industry distribution chart, Birzeit Pharmaceutical Co ranks #317 out of 515 companies in the Drug Manufacturers industry, placing it in the top 61.6%.
Is Birzeit Pharmaceutical Co's Dividend Yield % too high?
Birzeit Pharmaceutical Co's current Dividend Yield % of 1.36% is 62% below median its 10-year median of 3.59. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 6.33. The Drug Manufacturers industry median Dividend Yield % is 1.93. Birzeit Pharmaceutical Co's value of 1.36% is 29.5% below this industry median. Based on the distribution chart, Birzeit Pharmaceutical Co ranks #317 out of 515 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Birzeit Pharmaceutical Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Birzeit Pharmaceutical Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Birzeit Pharmaceutical Co ranks #317 out of 515 companies for Dividend Yield %. This places Birzeit Pharmaceutical Co in the lower half of its industry. The industry median Dividend Yield % is 1.93. Birzeit Pharmaceutical Co's value of 1.36% is 29.5% below this benchmark. Historically, Birzeit Pharmaceutical Co's own Dividend Yield % has ranged from 1.12 to 6.33 over the past decade. While the company's 10-year median is 3.59 vs. the industry median of 1.93, Birzeit Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.93, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Birzeit Pharmaceutical Co's current Dividend Yield % of 1.36% is 29.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Birzeit Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Birzeit Pharmaceutical Co's current Dividend Yield % is 1.36%, which is 62% below median its own 10-year median of 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Birzeit Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Birzeit Pharmaceutical Co (XPAE:BPC) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.59, compared to a current price of $3.67 — trading 20% below its estimated fair value. The current Dividend Yield % is 1.36%, which is 62% below median its 10-year median of 3.59 and 29.5% below the Drug Manufacturers industry median of 1.93. Birzeit Pharmaceutical Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Birzeit Pharmaceutical Co (XPAE:BPC), the current Dividend Yield % is 1.36% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Birzeit Pharmaceutical Co (XPAE:BPC) Overvalued in 2026?
Based on GuruFocus' analysis, Birzeit Pharmaceutical Co stock appears to be undervalued.
The current stock price of $3.67 is trading 20% below its estimated GF Value™ of $4.59.
GuruFocus considers Birzeit Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for XPAE:BPC:
Dividend Yield %: 1.36% (62% below median its 10-year median of 3.59)
GF Value™: $4.59 vs. price of $3.67 (20% below fair value)
Industry Position: 29.5% below the Drug Manufacturers median (#317 of 515)
No single metric tells the full story. See the XPAE:BPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Birzeit Pharmaceutical Co operates as a pharmaceutical manufacturer in Palestine, producing a range of approximately 270 products across various production lines at four locations. Its portfolio comprises brands spanning multiple therapeutic areas. In addition to manufacturing, the company supplies its products to the local market through pharmacies and medical professionals.
91GF Score
Get the complete analysis for XPAE:BPC
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAE:BPC has been successfully added to your 
